Revenue stood in line with our estimate. Two-year revenue CAGR stood at 14%, driven by the ECD segment (+18%). Cost rationalization, favorable mix, and pricing action mitigated the impact of commodity cost inflation QoQ, which led to EBITDA coming in higher than our estimate, despite higher YoY employee costs and other expenses (excluding ad spends). With commodity costs inching up in 2QFY22 as well, the management addressed this via: a) product premiumization, b) cost savings (of INR480m in 2QFY22), and c) price hikes of 3-4%....